Hartford International Opportunities HLS Fund Class IB HBIOX

Medalist Rating as of | See Hartford Funds Investment Hub
  • NAV / 1-Day Return 23.25  /  +0.65 %
  • Total Assets 860.2M
  • Adj. Expense Ratio
    1.010%
  • Expense Ratio 1.010%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 1.15%
  • Turnover 43%

USD | NAV as of Aug 08, 2026 | 1-Day Return as of Aug 08, 2026, 12:11 AM GMT+0

Morningstar’s Analysis HBIOX

Will HBIOX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Not yet proven in its current configuration. It’s still fairly early days for Hartford International Opportunities’ current skipper and modified version of its long-standing approach. The strategy retains its Average People and Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HBIOX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Taiwan Semiconductor Manufacturing Co Ltd

7.38 64M
Technology

SK hynix Inc

4.33 38M
Technology

ASML Holding NV

3.40 29M
Technology

Samsung Electronics Co Ltd

3.15 27M
Technology

Royal Bank of Canada

2.24 19M
Financial Services

Tencent Holdings Ltd

1.87 16M
Communication Services

Siemens AG

1.79 16M
Industrials

AstraZeneca PLC

1.77 15M
Healthcare

TotalEnergies SE

1.76 15M
Energy

Societe Generale SA

1.72 15M
Financial Services

Sponsor Center